Home » Topics » Ocular, BioWorld Science

Ocular, BioWorld Science
RSS

New calpain inhibitors, their preparation and use, reported by Senju team

Nov. 26, 2003

DES may facilitate repair of damaged nerve cells

Nov. 19, 2003

Two phase III studies for Retaane planned for January

Nov. 18, 2003

Inhibition of glutamate carboxypeptidase II as a novel approach to diabetic retinopathy

Nov. 14, 2003

Lexicon moves into ophthalmology

Nov. 11, 2003

NDA accepted for antiinflammatory-antibiotic combination product

Nov. 7, 2003

AL-2512 as a potentially safer ocular antiinflammatory agent

Oct. 21, 2003

Visudyne approved in Japan for wet AMD

Oct. 20, 2003

Characterization of SU-10944, an orally active small-molecule inhibitor of VEGFR-2

Oct. 14, 2003

FDA accepts Vitrase NDA for filing

Oct. 10, 2003

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...